Reaction
Carbohydrate Antigen 15-3 Increased reporting signals
As of the last recalculation, Carbohydrate Antigen 15-3 Increased appears in 752 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is FULVESTRANT (PRR 315.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fulvestrant | 251 | 315.2 | 317.6 |
| Ribociclib | 240 | 308.7 | 311.0 |
| Letrozole | 302 | 226.1 | 227.2 |
| Letrozole Tablets | 255 | 221.5 | 222.7 |
| Goserelin | 52 | 115.1 | 115.5 |
| Anastrozole Tablets | 77 | 110.5 | 110.9 |
| Exemestane | 74 | 105.9 | 106.3 |
| Zoledronic Acid | 106 | 84.9 | 85.1 |
| Anastrozole | 98 | 84.8 | 85.0 |
| Alpelisib | 21 | 68.6 | 68.7 |
| Palbociclib | 177 | 66.9 | 67.0 |
| Abemaciclib | 29 | 41.7 | 41.8 |
| Everolimus | 66 | 39.3 | 39.3 |
| Everolimus Tablets | 23 | 39.1 | 39.2 |
| Capecitabine | 100 | 34.7 | 34.8 |
| Pertuzumab | 25 | 26.3 | 26.3 |
| Ado-Trastuzumab Emtansine | 7 | 23.2 | 23.2 |
| Denosumab | 138 | 22.9 | 22.9 |
| Telmisartan | 14 | 22.1 | 22.1 |
| Lisinopril And Hydrochlorothiazide | 8 | 21.9 | 21.9 |
| Paclitaxel (Aibumin-Bound) | 42 | 14.9 | 14.9 |
| Trastuzumab | 34 | 14.3 | 14.3 |
| Paclitaxel | 48 | 14.3 | 14.3 |
| Lisinopril And Hydrochlorothiazide Tablets | 4 | 14.2 | 14.2 |
| Olaparib | 10 | 13.4 | 13.4 |
| Lapatinib | 7 | 12.6 | 12.6 |
| Docetaxel Anhydrous | 26 | 11.0 | 11.0 |
| Docetaxel | 26 | 11.0 | 11.0 |
| Gemcitabine | 15 | 10.7 | 10.7 |